Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 13 / Drugs : 14 - (DrugBank : 4) / Drug target genes : 18 - Drug target pathways : 9

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Dichlorphenamide
   National Center for Research Resources (NCRR)
      1992   Phase 3   NCT00004802   -
Lamotrigin actavis
   Grete Andersen
      2013   -   EUCTR2013-003309-24-DK   Denmark
Lamotrigin ”nordic prime 100 MG
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Lamotrigin ”nordic prime 25 MG
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Lamotrigin ”nordic prime 50 MG
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Lamotrigine
   Grete Andersen
      2013   -   EUCTR2013-003309-24-DK   Denmark
   Grete Andersen, MD
      2022   -   NCT05639257   Denmark
      2013   Phase 3   NCT01939561   Denmark
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Lamotrigine 25MG oral tablet, extended release
   University College, London
      2021   Phase 3   NCT05017155   United Kingdom
Mexiletina cloridrato
   FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
      2015   Phase 2   EUCTR2014-002627-10-IT   Italy
Mexiletine
   Assistance Publique - Hôpitaux de Paris
      2011   Phase 3   NCT02336477   France
   Dept. of Neurology - Univ. of Kansas Medical Center
      2010   -   EUCTR2009-011184-36-IT   Italy;United Kingdom
   Radboud University
      2014   Phase 2   NCT02045667   Netherlands
   Radboud University Nijmegen Medical Center
      2012   -   EUCTR2010-024026-38-NL   Netherlands
   Richard Barohn, MD
      2008   Phase 2   NCT00832000   Canada;Italy;United Kingdom;United States
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
   University College, London
      2021   Phase 3   NCT05017155   United Kingdom
Mexitil
   Radboud University Nijmegen Medical Center
      2012   -   EUCTR2010-024026-38-NL   Netherlands
Mexitil*20CPS 200MG
   Dept. of Neurology - Univ. of Kansas Medical Center
      2010   -   EUCTR2009-011184-36-IT   Italy;United Kingdom
Namuscla
   Grete Andersen, MD
      2022   -   NCT05639257   Denmark
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Ranolazine
   Ohio State University
      2014   Phase 1   NCT02251457   United States
Riluzolo teva - 50 MG compresse rivestite CON film 90 compresse IN blister AL/PVC
   FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
      2015   Phase 2   EUCTR2014-002627-10-IT   Italy